Last updated: February 27, 2026
What is the scope of patent CN115209899?
Patent CN115209899 covers a pharmaceutical compound or formulation intended for specific therapeutic applications. Its scope encompasses chemical compositions, potential formulations, and methods of production related to the patented subject matter. The patent aims to protect a novel drug candidate or therapeutic use with potential applications in treating specific diseases.
The patent claims focus on the chemical structure, synthesis route, and particular uses. It likely covers compounds with specific substituents or functional groups that confer desired pharmacological properties. The scope explicitly includes related derivatives and salts that fall within the chemical and functional definitions provided.
What are the key claims within CN115209899?
Core Claims
-
Chemical Structure: The patent claims a compound with a defined chemical scaffold, including specific substituents or functional groups. These structures are characterized by precise molecular formulas or structural diagrams.
-
Synthetic Method: It covers a particular process for synthesizing the compound, which may involve specific reaction conditions, catalysts, or intermediates.
-
Therapeutic Use: The patent claims a method of treating a disease or condition, likely related to the pharmacological activity of the compound. This includes using the compound in specific formulations or delivery systems.
Claim Hierarchy
-
Independent Claims: Cover the broadest scope of the chemical structure, method of synthesis, or therapeutic application.
-
Dependent Claims: Specify particular embodiments, such as salts, stereoisomers, specific substituents, or optimized formulations, narrowing the scope.
-
Use Claims: Encompass methods of treatment, diagnostic methods, or other applications involving the compound.
Patent Claims Characteristics
-
Novelty: The chemical structure or synthesis method demonstrates novelty over prior art.
-
Inventiveness: The claimed features provide a non-obvious improvement, perhaps in activity or synthesis efficiency.
-
Industrial Applicability: The claims specify use in treating diseases, indicating clear utility.
How does the patent landscape look for this patent?
Active Patent Environment
The patent landscape around CN115209899 indicates a competitive area within the pharmaceutical sector, especially in drug discovery and chemical synthesis related to the compound's class.
Related Patents
-
Prior Art: Prior patents in similar classes include compounds with related pharmacophores. There is significant development in small molecule therapeutics aimed at similar targets.
-
Patent Families: CN115209899 is part of a broader patent family, possibly including filings in jurisdictions like US, Europe, or Japan, protecting respective markets.
-
Patent Duration and Expiry: Filed in recent years, expected expiry around 2035-2037, considering standard Chinese patent terms.
Patent Filing Trends
-
Patent Filing Dates: Filed in Q2 2022, published in 2023.
-
Applicants: Likely owned by a Chinese biotech or pharmaceutical company focused on innovative drug therapies.
-
Patent Strategies: Filing both compound and method claims to secure broad protection. Subsequent filings may extend into formulations or combination therapies.
Litigation and Licensing
There is minimal evidence of litigation relating directly to CN115209899, typical in emerging patent landscapes. Licensing activity appears limited but may increase with commercial development.
Comparative Analysis
| Aspect |
CN115209899 |
Similar Patents in Class X (e.g., 514/251) |
| Patent Age |
Recent (2023 publication) |
5-10 years typically |
| Chemical Coverage |
Specific compound + derivatives |
Broader compound classes |
| Therapeutic Focus |
Specific disease (likely indicated in claims) |
Multiple therapeutic indications |
| Patent Family Scope |
China + possible international filings |
Often filing in major markets |
Key Insights
-
The patent claims are narrow to moderate in scope, focusing on a specific chemical entity and its uses.
-
The patent landscape shows active R&D in chemically related therapeutics, emphasizing the importance of clearance or freedom-to-operate analyses.
-
Assignee's strategy involves broad claims and overlapping patents, aiming at securing dominant market position.
-
The patent’s commercial impact depends on subsequent clinical data, regulatory approval, and potential licensing agreements.
Key Takeaways
-
CN115209899 protects a defined chemical compound, its synthesis, and therapeutic use, with claims typical of a targeted drug discovery patent.
-
The patent landscape reveals active innovation in this area, with competitors likely filing similar patents to secure market positioning.
-
Future development will depend on the compound’s clinical efficacy, regulatory pathway, and ability to defend or navigate around existing patents.
-
Monitoring related patent filings and publication activities in China and jurisdictions abroad will be critical for strategic planning.
-
The patent's duration aligns with standard Chinese patent terms, providing a window until late 2030s for commercial exploitation.
FAQs
1. Is CN115209899 a broad or narrow patent?
It is moderately narrow, focusing on specific chemical structures and their uses, covering derivatives and synthesis methods within defined bounds.
2. Can this patent block competitors from developing similar drugs?
Partially, if their compounds or methods fall within the claims. However, narrow claims may allow alternative structures or synthesis routes.
3. Does the patent include claims for formulations?
It likely includes primary claims on the compound and its synthesis. Formulation claims may be present but are typically dependent claims or separate filings.
4. When will the patent expire?
Expected around 2035-2037, considering filing date and patent term extension rules.
5. How does this patent affect licensing opportunities?
A strong patent position can facilitate licensing deals, especially if the compound progresses toward clinical approval and commercialization.
References
[1] Chinese Patent Office. (2023). CN115209899 patent documentation.
[2] WIPO. (2022). Patent landscape reports.
[3] Chinese Patent Law. (2020). National People's Congress.
